Frost & Sullivan, March 2007 ... such as melanoma and renal cell carcinoma... vaccines in late-stage development Pipeline overview ... Unit, Weatherall Institute of Molecular Medicine, University of ...
Greystone Associates, July 2008 ... associated with end-stage renal disease Personalized ... diagnostics Players in the development of personalized ... and distribution of personalized medicines Role of ...
CME Group, Oct 2008 ... 32 Immunotherapy 32 4. CORPORATE DEVELOPMENTS 35 Avexa to ... Approval for Erbitux from US Medicine Regulator 38 ... Approval for Sutent, a Kidney and Gastrointestinal ...
CME Group, Oct 2009 ... Target Identification and Predictive Medicine --3. Identification ... Detection of Damage to Kidney Liver or ... Biomarker Development for Traumatic Brain Injury --11. ...
Jain PharmaBiotech, Nov 2009, Pages: 334
... malignancies - Recognize principles of new developments in biologic ... Indiana University School of Medicine, Indianapolis, IN - Renal Cell Cancer...
CME Group, July 2008 ... of organ transplantation Personalization of kidney transplantation Personalization ... Players in the development of personalized ... of personalized medicines Role of ...
Timely Data Resources, Inc. ... malignancies - Recognize principles of new developments in biologic ... Indiana University School of Medicine, Indianapolis, IN Renal Cell Cancer...
Datamonitor, March 2008, Pages: 100
... 4.6 LAIV - The Institute of Experimental Medicine, St Petersburg ... Prostate cancer 78 4.1.3.7 Renal cancer 78 4.1 ... vaccines in Phase II clinical development 79 4.1 ...
CME Group, Aug 2009 ... human drug discovery and development Advantages and ... of gene therapy in veterinary medicine Gene therapy for ... for arthritis Gene therapy for renal failure Cancer...
Just Pharma Reports, Aug 2008, Pages: 81
... MD RIT for Colon and Renal Cancers Chaitanya ... MD Professor of Internal Medicine Division of ... Lister-James, PhD Vice President, Development Xanthus Pharmaceuticals ...
Takeda Pacific, Sep 2008, Pages: 147
... SEER) data Toxic Exposure Surveillance System (TESS) UK Renal Registry UK ... care as well as authoritative descriptions of new developments in medicine. ...
John Wiley and Sons Ltd, Aug 2009, Pages: 256
... SEER) data Toxic Exposure Surveillance System (TESS) UK Renal Registry UK ... care as well as authoritative descriptions of new developments in medicine. ...
TriMark Publications, April 2009, Pages: 320
... of the breast, lung, prostate, kidney and thyroid ... Table 25: Odanacatib: ongoing clinical development in bone ... Maeda Corporation Medicines Company, The Merck & Co ...
Global Industry Analysts, Inc., March 2008, Pages: 259
... of the most recent and pertinent developments in family ... Thomas W. Hejkal, MD, PhD - Sports Medicine and the ... Mark E. Rupp, MD - Chronic Kidney Disease Troy Plumb ...
MarketsandMarkets.com, Sep 2009, Pages: 189
... drug makers use certain kidney safety biomarker ... R&D + Biomarker/ --- Test Co-development -- Biomarkers, a ... Targeted Therapies -- Personalized Medicine is Here ...
Bizacumen Inc., Nov 2009, Pages: 229
... Lung Cancer 5.3.1.5 Sutent in Renal Cell Carcinoma... 4.2 Risk assessment of unlicensed medicines 5.1 High ... practice, 16 years in development, regulatory affairs ...
CME Group, Oct 2007 ... drug makers use certain kidney safety biomarker ... R&D + Biomarker/ --- Test Co-development -- Biomarkers, a ... Targeted Therapies -- Personalized Medicine is Here ...
Espicom Business Intelligence Ltd, July 2007, Pages: 306
... Glance: - Addresses the key principles of pathology that are central to medicine - Contains full ... 64 Developmental and inherited disorders ... 69 Renal cell carcinoma...